MRD-Directed Consolidation With Epcor-only or Epcor-R2 Post Anti-CD19 CAR TCell Therapy for Large B-Cell Lymphoma
Clinical trial NCT06414148 · RECRUITING
Trial details
- NCT number
- NCT06414148
- Sponsor
- Peter MacCallum Cancer Centre, Australia
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-14
- Primary completion
- 2026-10-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.